Keyphrases
Cluster of Differentiation 44 (CD44)
100%
Preclinical Evaluation
100%
Single-chain Variable Fragment
100%
Fragment Crystallizable
100%
Zirconium-89 (89Zr)
26%
Binding Site
7%
Tumor
7%
Extracellular Domain
7%
After Injection
7%
Epitope Mapping
7%
Hyaluronic Acid
7%
Tumor Uptake
7%
MDA-MB-231
7%
Cancer Therapy
3%
PET Imaging
3%
Recombinant Human
3%
Cell Proliferation
3%
Tumor Cells
3%
Cancer Stem Cells
3%
Breast Cancer
3%
Specific Antibodies
3%
Positron Emission Tomography-computed Tomography (PET-CT)
3%
Alternative Splicing
3%
Cell Survival
3%
Human IgG1
3%
Glycoprotein
3%
Human Tumors
3%
Monovalent Cations
3%
Clinical Investigation
3%
Tumor-specific
3%
Human Breast Cancer Cells
3%
Binding Affinity
3%
Cell Invasion
3%
Between-day
3%
Cell Signaling Pathways
3%
Biodistribution Studies
3%
Glycophorin A
3%
Antibody Constructs
3%
Injected Dose
3%
Athymic nude Mice
3%
In Vivo Biodistribution
3%
Overlapping Peptides
3%
Antibody Fragment
3%
Tumor-to-blood Ratio
3%
Triple Negative
3%
Specific Uptake
3%
Phage Display
3%
PET Imaging Agent
3%
Variable Binding
3%
Peptide Microarray
3%
Linear Epitope
3%
Recombinant Cells
3%
Immunology and Microbiology
Single-Chain Variable Fragment
100%
CD44
100%
Positron Emission Tomography
7%
Signal Transduction
7%
Binding Site
7%
Epitope Mapping
7%
Cancer Stem Cell
3%
Tumor Cell
3%
Monospecific Antibody
3%
Positron Emission Tomography-Computed Tomography
3%
Cell Survival
3%
Cancer Cell
3%
Glycoprotein
3%
Cell Proliferation
3%
Cell Invasion
3%
Binding Affinity
3%
Nude Mouse
3%
Immunoglobulin G1
3%
Phage Display
3%
Peptide Microarray
3%
Linear Epitope
3%